Bioprocess Technology Market Scope And Analysis

  • Report Code : TIPHE100001373
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 194
Buy Now

Bioprocess Technology Market Analysis and Scope (2023 to 2028)

Buy Now

Bioprocess Technology Market Report Bioprocess Technology Market Size and Share Bioprocess Technology Market Scope and Analysis

Bioprocess Technology Market Report Scope

Report Attribute Details
Market size in 2022 US$ 30.9 Billion
Market Size by 2028 US$ 77.09 Billion
Global CAGR (2022 - 2028) 16.8%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Type
  • Cell Culture Media Bioprocess
  • Chromatography Bioprocess
  • Consumables & Accessories
By Modality
  • Single Use and Multiple Use
By End User
  • Academic & Medical Institutions
  • Biopharmaceutical Companies
  • Research Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • STAMM Biotech
  • Lonza Group AG
  • Eppendorf SE
  • Repligen Corp
  • Danaher Corp

    • Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, and BioPharma Dynamics Ltd are among the leading players operating in the global bioprocess technology market growth. Several other essential market players were analyzed for a holistic view of the market and its ecosystem. The report provides detailed market insights, which help the key players strategize their market growth. A few developments are mentioned below:

    • In June 2022, Merck has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.
    • In March 2020, Sartorius launched BIOSTAT STR Generation 3 single-use bioreactor and BIOBRAIN automation platform to introduce innovations that will change the field of biopharmaceutical process development and manufacturing. Biostat STR simplifies biologics production.

    Company Profiles

    • Merck KGaA           
    • Sartorius AG          
    • Thermo Fisher Scientific Inc          
    • Corning Inc            
    • STAMM Biotech       
    • Lonza Group AG      
    • Eppendorf SE         
    • Repligen Corp         
    • Danaher Corp         
    • BioPharma Dynamics Ltd